Towards Healthcare
U.S. Clinical Trial Imaging Market to Rise at 9.37% CAGR till 2034

U.S. Clinical Trial Imaging Market Advancing Precision Medicine

Projections indicate that, the U.S. clinical trial imaging market will increase from USD 684 million in 2024 to USD 1675.4 million by 2034, experiencing a CAGR of 9.37% over the next 10 years. Rising pharma & biotech R&D spend/more clinical trials are estimated to drive the growth of the market. Sponsors are running more and larger trials (especially in oncology, neurology, and immunology), increasing demand for imaging services to measure endpoints and safety. 

Content

  • Insight Code: 6255
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The U.S. clinical trial imaging market currently in 2025 records USD 748.09 million and is anticipated to grow to USD 1675.4 million by 2034, advancing at a CAGR of 9.37% from 2024 to 2034.

Northeast U.S. is leading the U.S. clinical trial imaging market due to the increasing clinical trial and demand of personalized medicines, rising investment & funding, and presence of major key players.

Key trends include the rising adoption of inorganic growth strategies, investment & funding, and decentralized and remote imaging, among others.

Imaging provides non-invasive, quantifiable data to assess drug safety, pharmacokinetics, and early efficacy, helping refine trial design and dosing strategies.

ACRP: Association of Clinical Research Professionals, SOCRA: The Society of Clinical Research Associates, Inc., Personalized Medicine Coalition, PCAB Accreditation for Compounding Pharmacies
Any Questions